Related Experiment Video
Updated: Jun 9, 2026
13:09
Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Potential pathomechanisms of ADHD based on neurometabolite changes
Veronika Husarova1, Igor Ondrejka, Ingrid Tonhajzerova
1Clinic of Psychiatry, Department of Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. nika.husarova@gmail.com
Neuro Endocrinology Letters
|August 31, 2010
Summary
Attention deficit hyperactivity disorder (ADHD) is a common childhood disorder. Magnetic resonance spectroscopy studies suggest brain network dysfunction and neurotransmitter imbalances may underlie ADHD symptoms.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Attention deficit hyperactivity disorder (ADHD) is a prevalent childhood psychiatric condition.
- The precise underlying pathomechanisms for ADHD core symptoms (hyperactivity, impulsivity, inattention) remain incompletely understood.
- Potential contributing factors include developmental dysfunction in the cortical-striatal-thalamic-cortical network and catecholamine neurotransmitter dysregulation.
Purpose of the Study:
- To explore potential pathomechanisms of ADHD.
- To investigate the role of brain biochemistry and metabolism in ADHD.
- To evaluate the utility of magnetic resonance spectroscopy in understanding ADHD.
Main Methods:
- Review of studies utilizing magnetic resonance spectroscopy (MRS).
- Analysis of in vivo brain measurements.
- Correlation of MRS findings with ADHD symptoms and proposed neurobiological models.
Main Results:
- MRS provides insights into molecular mechanisms of brain biochemical and metabolic processes.
- Evidence suggests a link between MRS-detectable brain alterations and ADHD.
- Hypothesized pathomechanisms involving catecholamine dysregulation and network dysfunction are supported by MRS data.
Conclusions:
- Magnetic resonance spectroscopy is a valuable tool for investigating the neurobiological underpinnings of ADHD.
- Further research using MRS can elucidate the complex pathomechanisms of ADHD.
- Understanding these mechanisms may lead to improved diagnostic and therapeutic strategies for ADHD.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...